Piccina Cintia

Insider profile

Performance

Overall performance
2.9

Performance over holding periods
2.9
30 days 90 days 120 days
Average return -9% 8.2% 15.1%
Success rate 25% 68% 82%
Transactions
4 0% Buy
34 71% Buy
47 69% Buy
Piccina Cintia's trades of Adaptimmune Therapeutics PLC's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-01-15 2025-01-15 PrS Proposed sale
11,944
310.69
US$4,171,486
11,944 310.69 US$4,171,486
2025-01-15 2025-01-15 S Sale
30,319 +17.0%
459.84
US$4,941,541
30,319 +17.0% 459.84 US$4,941,541
2024-06-18 2024-06-18 S Sale
26,391 -49.3%
275.08
US$3,008,153
26,391 -49.3% 275.08 US$3,008,153
2023-01-31 2023-01-31 S Sale
11,890 -37.8%
1.87
US$22,230
11,890 -37.8% 1.87 US$22,230
2022-08-01 2022-08-01 S Sale
21,040 -37.7%
1.77
US$37,314
21,040 -37.7% 1.77 US$37,314